ClinicalTrials.Veeva

Menu

Constitution of Cerebrospinal Fluid and Blood Database/Specimen in Acute Stage of Subarachnoid Hemorrhage (aSAH) Patients

U

University of Regensburg (UR)

Status

Unknown

Conditions

Subarachnoid Hemorrhage

Study type

Observational

Funder types

Other

Identifiers

NCT01292278
CSF 06/179

Details and patient eligibility

About

Neuropeptide Y (NPY) may play a major role in the pathophysiology of aneurysmal subarachnoid hemorrhage (aSAH). To investigate the correlation of NPY in cerebrospinal fluid (CSF) and blood (serum) and the neurological outcome in the acute stage of aSAH.

Full description

Evaluation of Neuropeptides in CSF and serum in SAH patients

Enrollment

90 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • spontaneous or aneurysmal subarachnoid hemorrhage

Exclusion criteria

  • age younger than 18 years or older than 70 years
  • inflammatory disease
  • history of former SAH
  • no ventricular drainage

Trial design

90 participants in 2 patient groups

aSAH
Description:
consecutive patients with spontaneous or aneurysmal subarachnoid hemorrhage
control group
Description:
no neurological disease but spinal anesthesia

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems